本能
医学
肠道菌群
疾病
连接(主束)
神经科学
免疫学
生态学
病理
生物
结构工程
工程类
作者
Vasu Peddinti,Manoj Mohan Avaghade,Sunil Suthar,Biswajit Rout,Shyam Sudhakar Gomte,Tejas Girish Agnihotri,Aakanchha Jain
标识
DOI:10.1016/j.clnesp.2024.02.019
摘要
Alzheimer's disease (AD) is a neurodegenerative disorder marked by neuroinflammation and gradual cognitive decline. Recent research has revealed that the gut microbiota (GM) plays an important role in the pathogenesis of AD through the microbiota-gut-brain axis. However, the mechanism by which GM and microbial metabolites alter brain function is not clearly understood. GM dysbiosis increases the permeability of the intestine, alters the blood-brain barrier permeability, and elevates proinflammatory mediators causing neurodegeneration. This review article introduced us to the composition and functions of GM along with its repercussions of dysbiosis in relation to AD. We also discussed the importance of the gut-brain axis and its role in communication. Later we focused on the mechanism behind gut dysbiosis and the progression of AD including neuroinflammation, oxidative stress, and changes in neurotransmitter levels. Furthermore, we highlighted recent developments in AD management, such as microbiota-based therapy, dietary interventions like prebiotics, probiotics, and fecal microbiota transplantation. Finally, we concluded with challenges and future directions in AD research based on GM.
科研通智能强力驱动
Strongly Powered by AbleSci AI